| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/03/1996 | CN1032209C Process for preparing 2-piperidino-1-alkanol derivatives as antiischemic agents |
| 07/03/1996 | CN1032208C Process of preparing amides and their addin salts for medical use |
| 07/03/1996 | CN1032207C Process for preparing imidazopyrazole derivatives, witch use as analgesics and anti-inflammatory agents |
| 07/03/1996 | CN1032206C Process for preparing tetrahydrofolic acid |
| 07/03/1996 | CN1032205C Process of preparing purinyl and pyrimidinyl-cyclo butane derivatives |
| 07/03/1996 | CN1032204C Process for preparing acetylenes disubstituted with phenyl group and heterobicyclic group having retinoid like activity |
| 07/03/1996 | CN1032203C Process for preparing substituled 2-pyridones and pyrid-2-thiones |
| 07/03/1996 | CN1032202C Process for preparation of 6-substituted-hexahydrobenz (CD) indoles |
| 07/03/1996 | CN1032190C Method for reducing side effects of drug |
| 07/02/1996 | US5532925 Current-to-pressure transducer with selectable, adjustable input filter |
| 07/02/1996 | US5532415 Monoamine oxidase inhibitors; parkinson's disease, nervous system disorders; cognition activators |
| 07/02/1996 | US5532400 2,6-di-alkyl-4-silyl-phenols as antiatheroscelerotic agents |
| 07/02/1996 | US5532388 Preparation of antitumor agents |
| 07/02/1996 | US5532387 Cyclization of trimethylhydroquinone and an alkenyl alcohol, reusable catalyst, iiib fluorosulfonate, nitrate, sulfate, or fluoroalkylsulfonate |
| 07/02/1996 | US5532383 Leukotriene B4 antagonists |
| 07/02/1996 | US5532375 Process for preparing 1,2,5,6-tetrahydropyridin-3-carboxaldehyde oximes |
| 07/02/1996 | US5532372 With a 1,2-benzisothiazole ring attached at its 3-position to a piperazine nitrogen; antipsychotics; includes lurasidone in claim 17 |
| 07/02/1996 | US5532368 Xanthine derivatives with adenosine-antagonistic activity |
| 07/02/1996 | US5532363 Heteroaryl substituted oxazinone compounds for the preparation of taxol |
| 07/02/1996 | US5532359 Fungicides |
| 07/02/1996 | US5532357 Method for preparing N-monosubstituted and N,N'-disubstituted unsymmetrical cyclic ureas |
| 07/02/1996 | US5532355 Carbamates of rapamycin |
| 07/02/1996 | US5532354 Antibiotics |
| 07/02/1996 | US5532337 Proteins comprising calmodulin- and actin-binding human caldesmon polypeptide fragments |
| 07/02/1996 | US5532305 Hyaluronic acid and cationic polyacrylic acid copolymer for time release agents |
| 07/02/1996 | US5532278 Methods and compositions for treating urinary incontinence using optically pure (S)-oxybutynin |
| 07/02/1996 | US5532277 Spin trap nitronyl hindered phenols |
| 07/02/1996 | US5532276 Angiotensin ii antagonists, hypotensive |
| 07/02/1996 | US5532275 P-aminobenzoic acid or the sodium or potassium salts |
| 07/02/1996 | US5532274 Levodopa, carbidopa, vinyl acetate-vinyl alcohol copolymer |
| 07/02/1996 | US5532271 Treatment of rheumatoid arthritis, multiple sclerosis, encephalomyelitis, hemolytic anemia |
| 07/02/1996 | US5532270 Topical chroman compound |
| 07/02/1996 | US5532269 Administering thioctic acid or derivatives; vasodilation; side effect reduction |
| 07/02/1996 | US5532268 Increasing the serotonin, norepinephrine and dopamine in the brain using fluoxetine and alprenolol, spiperone, tetratolol and propranolol |
| 07/02/1996 | US5532266 Treatment of hypoxia, antiedemic agents or antiinflammatory agents |
| 07/02/1996 | US5532265 Administering n-(2r-2-(hydroxamidocarbonylmethyl)-4-methylpentanoyl-l-trypt ophan methylamine to a mammal |
| 07/02/1996 | US5532264 Potentiation of venlafaxine, milnacipran and duloxetine to increase available serotonin, norepinephrine and dopamine in the brain by administering oxyalkylamine derivatives |
| 07/02/1996 | US5532263 Benzothiopyranoindazole antitumor agents |
| 07/02/1996 | US5532259 Isoxazole-4-carboxamides and hydroxyalkylidenecyanoacetamides, pharmaceuticals containing these compounds and their use |
| 07/02/1996 | US5532258 Antiulcer agents |
| 07/02/1996 | US5532257 Benzothiazole compound, production thereof and use thereof |
| 07/02/1996 | US5532255 Anticoagulants, cardiovascular disorders, antiinflammatory agents, arteriosclerosis or antitumor agents |
| 07/02/1996 | US5532254 Modulation of calcium channels using benzothiophenes |
| 07/02/1996 | US5532253 Enzyme inhibitors as anticoagulants |
| 07/02/1996 | US5532251 Analgesics and cardiovascular disorders |
| 07/02/1996 | US5532250 Administering a serotonin 1a receptor antagonist: alprenolol, pindolol, propranolol, or tertatolol, with fluoxetine, venlafaxine, milnacipran ro duloxetine |
| 07/02/1996 | US5532249 Alzheimers |
| 07/02/1996 | US5532248 O-aryl,O-alkyl, and O-alkenyl-macrolides having immunosuppressive activity |
| 07/02/1996 | US5532246 Use of 1,3-oxathiolane nucleoside analogues in the treatment of hepatitis B |
| 07/02/1996 | US5532245 To reduce smooth muscle contractions; treatment for urinary incontinence, iritable bowel syndrome |
| 07/02/1996 | US5532244 Potentiation of drug response |
| 07/02/1996 | US5532243 Antipsychotic nitrogen-containing bicyclic compounds |
| 07/02/1996 | US5532242 Central nervous system cognition activators, anxiety and antidepressants |
| 07/02/1996 | US5532241 Cns activity |
| 07/02/1996 | US5532239 For the treatment of nephrotic syndromes |
| 07/02/1996 | US5532237 Intraocular for treatment of glaucoma |
| 07/02/1996 | US5532236 [1,2,4]triazolo[4,3-a]quinoxaline compounds |
| 07/02/1996 | US5532235 Tricyclic benzazepine vasopressin antagonists |
| 07/02/1996 | US5532234 Use of 1-[4-[4-aryl (or heteroaryl)-1-piperazinyl]-butyl)-1H-azole derivatives for the preparation of medicaments intended for the treatment of disorders of gastric secretion |
| 07/02/1996 | US5532233 Platelet activating factor antagonist |
| 07/02/1996 | US5532232 Inhibit thrombin induced platelet aggregation; fibrinogen anticoagulants in blood |
| 07/02/1996 | US5532230 Administering dehydroepiandrosterone or derivatives as antiischemic agent |
| 07/02/1996 | US5532229 Cream of vitamin d |
| 07/02/1996 | US5532227 Tetracyclines including non-antimicrobial chemically-modified tetracyclines inhibit excessive glycosylation of different types of collagen and other proteins during diabetes |
| 07/02/1996 | US5532226 Trifluoromethybenzylphosphonates useful in treating osteoporosis |
| 07/02/1996 | US5532223 Use of aqueous soluble glucan preparations to stimulate platelet production |
| 07/02/1996 | US5532221 Ionically crosslinked carboxyl-containing polysaccharides for adhesion prevention |
| 07/02/1996 | US5532219 Dapsone and promin for the treatment of dementia |
| 07/02/1996 | US5532218 Antitumor agents |
| 07/02/1996 | US5532214 Anti-HIV protein, TAP 29, from tricosanthes, DNA coding therefor and therapeutic uses thereof |
| 07/02/1996 | US5532154 Mutated alpha virus |
| 07/02/1996 | US5532029 Sunscreen, agricultural chemicals |
| 07/02/1996 | US5532003 Pentoxifylline therapy |
| 07/02/1996 | US5530966 Protective garment for baseball umpires having an inner cushioned layer and an outer layer of interconnected plates |
| 07/02/1996 | CA2078347C Use of copper(ii) containing compounds to accelerate wound healing |
| 07/02/1996 | CA2059129C Encapsulation process |
| 07/02/1996 | CA1338432C Esters of 3-demethylthiocolchicine and n-acyl analogs |
| 06/30/1996 | CA2166234A1 3-phenylisoquinol-1(2h)-one derivatives, their preparation and their therapeutic application |
| 06/30/1996 | CA2166233A1 8-oxo-5,8-dihydro-6h-dibenzo¬a,g|quinolizine-13-propanoic acid derivatives, their preparation and their therapeutic application |
| 06/29/1996 | CA2166168A1 Esculetin derivatives, method for manufacture thereof, and pharmaceutical composition |
| 06/29/1996 | CA2166165A1 Substituted 4-phenylthiazole derivatives, process for their preparation and pharmaceutical compositions containing them |
| 06/29/1996 | CA2166152A1 Optically active benzothiepin derivative, its preparation and use |
| 06/28/1996 | CA2164044A1 Composition containing pharmaceutically effective amount of thiadiazole compound for treatment of central nervous system tumor types |
| 06/27/1996 | WO1996019583A1 Recombinant proteinase from clostridium hystolyticum and the use thereof for isolating cells and cell groups |
| 06/27/1996 | WO1996019580A2 Telomerase protein component |
| 06/27/1996 | WO1996019491A1 Heterocyclic keto arginine peptides as thrombin inhibitors |
| 06/27/1996 | WO1996019490A1 Vitamin b12-containing sallow thorn concentrates or extracts |
| 06/27/1996 | WO1996019483A1 Low molecular weight bicyclic thrombin inhibitors |
| 06/27/1996 | WO1996019482A1 Thienoxazinone derivatives useful as antiviral agents |
| 06/27/1996 | WO1996019477A1 Tetracyclic spiro compounds, process for their preparation and their use as 5ht1d receptor antagonists |
| 06/27/1996 | WO1996019476A1 Novel quinoxalines and drugs prepared therefrom |
| 06/27/1996 | WO1996019475A1 Fibrinogen receptor antagonists |
| 06/27/1996 | WO1996019474A1 Quinazolines as inhibitors of endothelin converting enzyme |
| 06/27/1996 | WO1996019473A1 New derivatives of pyroglutaminic acid, preparation process and applications |
| 06/27/1996 | WO1996019472A1 8-alkoxyquinolonecarboxylic acid hydrate with excellent stability and process for producing the same |
| 06/27/1996 | WO1996019469A1 Diaryl-2-(5h)-furanones as cox-2 inhibitors |
| 06/27/1996 | WO1996019467A1 Substituted thiadiazoles, compositions containing them and their use as antimicrobial and marine antifouling agents |
| 06/27/1996 | WO1996019463A1 Heteroaromatic oxazole compounds and use thereof |
| 06/27/1996 | WO1996019462A1 Oxazole derivatives and use thereof |
| 06/27/1996 | WO1996019460A1 2-carbamoyl-1,4,5,6-tetrahydropyrazines |